Matches in Wikidata for { <http://www.wikidata.org/entity/Q36163040> ?p ?o ?g. }
- Q36163040 description "2012 nî lūn-bûn" @default.
- Q36163040 description "2012 ജൂണ് 25നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്രീയ ലേഖനം" @default.
- Q36163040 description "2012年の論文" @default.
- Q36163040 description "2012年論文" @default.
- Q36163040 description "2012年論文" @default.
- Q36163040 description "2012年論文" @default.
- Q36163040 description "2012年論文" @default.
- Q36163040 description "2012年論文" @default.
- Q36163040 description "2012年论文" @default.
- Q36163040 description "2012年论文" @default.
- Q36163040 description "2012年论文" @default.
- Q36163040 description "2012年论文" @default.
- Q36163040 description "2012年论文" @default.
- Q36163040 description "2012年论文" @default.
- Q36163040 description "2012년 논문" @default.
- Q36163040 description "article científic" @default.
- Q36163040 description "article scientific" @default.
- Q36163040 description "article scientifique (publié 2012)" @default.
- Q36163040 description "articol științific" @default.
- Q36163040 description "articolo scientifico" @default.
- Q36163040 description "artigo científico (publicado na 2012)" @default.
- Q36163040 description "artigo científico (publicado na 2012)" @default.
- Q36163040 description "artigo científico" @default.
- Q36163040 description "artikull shkencor" @default.
- Q36163040 description "artikulong pang-agham" @default.
- Q36163040 description "artykuł naukowy" @default.
- Q36163040 description "artículo científico publicado en 2012" @default.
- Q36163040 description "artículu científicu espublizáu en 2012" @default.
- Q36163040 description "bilimsel makale" @default.
- Q36163040 description "bài báo khoa học" @default.
- Q36163040 description "mokslinis straipsnis" @default.
- Q36163040 description "naučni članak" @default.
- Q36163040 description "scienca artikolo" @default.
- Q36163040 description "scientific article" @default.
- Q36163040 description "teaduslik artikkel" @default.
- Q36163040 description "tieteellinen artikkeli" @default.
- Q36163040 description "tudományos cikk" @default.
- Q36163040 description "vedecký článok" @default.
- Q36163040 description "vetenskaplig artikel" @default.
- Q36163040 description "videnskabelig artikel (udgivet 2012)" @default.
- Q36163040 description "vitenskapelig artikkel" @default.
- Q36163040 description "vitskapeleg artikkel" @default.
- Q36163040 description "vědecký článek" @default.
- Q36163040 description "wetenschappelijk artikel" @default.
- Q36163040 description "wissenschaftlicher Artikel" @default.
- Q36163040 description "επιστημονικό άρθρο" @default.
- Q36163040 description "мақолаи илмӣ" @default.
- Q36163040 description "мақолаи илмӣ" @default.
- Q36163040 description "наукова стаття, опублікована в червні 2012" @default.
- Q36163040 description "научна статия" @default.
- Q36163040 description "научная статья" @default.
- Q36163040 description "научни чланак" @default.
- Q36163040 description "научни чланак" @default.
- Q36163040 description "գիտական հոդված" @default.
- Q36163040 description "מאמר מדעי" @default.
- Q36163040 description "سائنسی مضمون" @default.
- Q36163040 description "مقالة علمية" @default.
- Q36163040 description "مقالهٔ علمی" @default.
- Q36163040 description "২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q36163040 description "บทความทางวิทยาศาสตร์" @default.
- Q36163040 description "სამეცნიერო სტატია" @default.
- Q36163040 name "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 name "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 name "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 type Item @default.
- Q36163040 label "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 label "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 label "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 prefLabel "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 prefLabel "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 prefLabel "A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515." @default.
- Q36163040 P1433 Q36163040-A56A5F59-840A-4469-92E0-EAEE3BCF86E6 @default.
- Q36163040 P1476 Q36163040-91A45DB5-A62B-4EC6-83AA-BFB5BCC2C7E2 @default.
- Q36163040 P2093 Q36163040-115195EF-72CD-4EB8-BE63-E0BC5EE4A2D7 @default.
- Q36163040 P2093 Q36163040-1C4B40E7-97F6-49ED-B57A-B29D2BF59F7D @default.
- Q36163040 P2093 Q36163040-249AF12D-E96F-47D4-9FB9-88BBFDA02407 @default.
- Q36163040 P2093 Q36163040-32E52D29-13D1-4F4A-A689-6827733AD713 @default.
- Q36163040 P2093 Q36163040-3E6B4C5D-AA04-49BF-9064-189EE78DEEC2 @default.
- Q36163040 P2093 Q36163040-64C5EE2F-1F23-439D-A469-32847702638D @default.
- Q36163040 P2093 Q36163040-B29B36FC-9F59-4233-902B-346F9C9BD111 @default.
- Q36163040 P2093 Q36163040-BE5F2AC7-8090-4CCF-B2EC-310BEE291757 @default.
- Q36163040 P2093 Q36163040-FB5BE776-C986-489C-96F7-86F5FB9B2696 @default.
- Q36163040 P2860 Q36163040-0D4F9566-71C9-46F1-9C1A-E6D5A20E83AF @default.
- Q36163040 P2860 Q36163040-0E3C4D2B-30C2-452D-A895-B1B0B984337C @default.
- Q36163040 P2860 Q36163040-0F32F482-E5D2-49A9-9403-FED7382B5D11 @default.
- Q36163040 P2860 Q36163040-185EA778-9385-4442-B34B-B9B00441F1F6 @default.
- Q36163040 P2860 Q36163040-1E03832F-D427-4480-9E9C-FEB1EDF99924 @default.
- Q36163040 P2860 Q36163040-1F5E2FD3-C12D-4FAF-8DAB-9482FEEF9BF5 @default.
- Q36163040 P2860 Q36163040-2678D07E-2D09-4A01-AFF6-DE65C33B97E3 @default.
- Q36163040 P2860 Q36163040-2D903404-94DF-477D-819F-4F4B1390499E @default.
- Q36163040 P2860 Q36163040-322BC85D-14A2-414B-8FD6-DD0692CFD0CF @default.
- Q36163040 P2860 Q36163040-335F41FD-992A-418B-AC41-B6E93C02C3E0 @default.
- Q36163040 P2860 Q36163040-37853AF3-5B77-42D4-A3DB-CCC2A7C62908 @default.
- Q36163040 P2860 Q36163040-3844F94E-7169-493B-BB93-9999C32416D6 @default.
- Q36163040 P2860 Q36163040-484CDD70-6866-4307-8833-950EA27F5738 @default.
- Q36163040 P2860 Q36163040-524B3103-53FE-4C4E-A04B-FC3CD5D7C063 @default.
- Q36163040 P2860 Q36163040-578A9566-EE64-40C8-9A13-AF544410626D @default.
- Q36163040 P2860 Q36163040-5A45D044-1DBB-44CD-B399-0BF444AA6B32 @default.
- Q36163040 P2860 Q36163040-6B57C4AE-DFBD-4E9E-BAA0-4650D284D07C @default.
- Q36163040 P2860 Q36163040-6F6AD304-9A46-432F-A202-EA899E935596 @default.